Xestoquinone treatment promoted the expression of several apoptotic markers including Annexin V externalization, PARP, caspases-3 and -7 in Molt4, K562, SupT1, and U937 leukemia cell lines (Figure 5a,b). The gene discussed is ANXA5; the disease is leukemia.